Viral claim: dandelion root kills cancer cells

A viral social-media claim on May 14 said dandelion root “kills” more than 90% of colon cancer cells in under 48 hours. The figure traces to a 2016 paper in the journal Oncotarget, not to a new human study released this week. The paper reported that an aqueous dandelion root extract triggered programmed cell death in more than 95% of colon cancer cells within 48 hours in laboratory experiments, and slowed tumor growth in mouse xenograft models after oral dosing. Those findings were preclinical — in cells and animals — and do not establish that dandelion root treats cancer in people. ### Where did the “48 hours” claim come from? A 2016 Oncotarget study by Pamela Ovadje and colleagues examined dandelion root extract in colon cancer cell lines and reported selective programmed cell death in more than 95% of colon cancer cells by 48 hours. The same paper said oral administration of the extract reduced growth in human colon xenograft mouse models by more than 90%. (oncotarget.com) The wording now circulating online compresses those results into a simple clinical-sounding claim. The study used an aqueous extract in controlled lab conditions, not whole dandelion root consumed as food or tea, and it did not show that patients with colon cancer were cured or treated successfully. ### Does that mean dandelion root is a proven cancer treatment? No major cancer authority cited in current public guidance says dandelion root is a proven cancer treatment in humans. (oncotarget.com) Cancer Research UK’s research information manager Marianne Baker told AFP there is “no scientific evidence” that dandelion extract is an effective cancer treatment and said any potential remedy would need rigorous trials to establish safety and effectiveness. Memorial Sloan Kettering Cancer Center says dandelion root extract has shown anticancer effects in cell lines, while public evidence remains preclinical. The gap matters because many compounds kill cancer cells in dishes but fail in humans. Cell-line studies can identify biological activity, but they do not answer whether a substance reaches tumors at the right dose, remains safe, or improves survival in patients. That is why oncology claims are normally tested through phased human trials before they are treated as clinical evidence. (factcheck.afp.com) ### Was there any human trial linked to this research? The University of Windsor said in February 2015 that researcher Siyaram Pandey had received approval to test dandelion root extract in patients with terminal cancer. But a current search result from ClinicalTrials.gov did not itself show a named, completed efficacy record tied to the viral colon-cancer claim, and the older University of Windsor announcement predates the current social-media post by more than a decade. (mskcc.org) CBC reported in 2020 that five years after the University of Windsor announced clinical trials into dandelion root extract, researchers had shifted attention to other plant extracts. That report does not amount to proof that no trial occurred, but it does show the viral post is not pointing to a newly established cancer therapy. (uwindsor.ca) ### Why are experts cautious about posts like this? AFP, Science Feedback, Full Fact and USA Today have all previously reviewed similar viral claims and said the lab findings were being presented without the context that they were not proven in humans. Those reviews drew the same distinction: preclinical results can be real and still fall far short of a demonstrated treatment. (cbc.ca) Memorial Sloan Kettering also notes that dandelion has biological activity and potential interactions, which is another reason cancer specialists caution against substituting supplements for standard care without physician oversight. Public supplement pages are not treatment endorsements, but they do underline that “natural” does not mean clinically validated or risk-free. (factcheck.afp.com) ### What is the cleanest way to read the claim? The accurate version is narrower than the viral one. A 2016 lab study reported that a specific dandelion root extract killed more than 95% of certain colon cancer cells within 48 hours in vitro, and the same paper reported tumor-growth reduction in mice. The evidence publicly visible today does not show that dandelion root has been proven to treat colon cancer in humans. (mskcc.org) ClinicalTrials.gov and updates from named institutions such as the University of Windsor would be the clearest places to watch for any future registered human data, safety results or peer-reviewed trial outcomes tied to dandelion root extract. (clinicaltrials.gov) (oncotarget.com)